Desq Long
Sign in

Company

REVELATION BIOSCIENCES, INC.

REVB · CIK 0001810560

SEC FORM 4
$0.00

REVELATION BIOSCIENCES, INC. (REVB)

Acquisition (code A) of 32,011 shares at $0 per share.

Reporting Person CARVER JENNIFER · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355658 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

REVELATION BIOSCIENCES, INC. (REVB)

Acquisition (code A) of 32,011 shares at $0 per share.

Reporting Person ROPER JESS · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355659 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

REVELATION BIOSCIENCES, INC. (REVB)

Acquisition (code A) of 208,073 shares at $0 per share.

Reporting Person Zygmont Chester Stanley III · Officer Title Chief Financial Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355661 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

REVELATION BIOSCIENCES, INC. (REVB)

Acquisition (code A) of 32,011 shares at $0 per share.

Reporting Person Chawla Lakhmir S · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355662 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

REVELATION BIOSCIENCES, INC. (REVB)

Acquisition (code A) of 208,076 shares at $0 per share.

Reporting Person Rolke James · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355663 · filed 2026-08-18 · View filing →